November 25, 2020

24X7 News Guru

The Real Time News

US expects to start Covid-19 vaccination program in early December: Official

Pfizer Inc. and BioNTech SE have submitted to FDA for emergency use authorisation after announcing that the final efficacy analysis of its vaccine candidate, BNT162b2, undergoing phase 3 trial met all of the study’s primary efficacy endpoints.

%d bloggers like this: